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Acquisition of the membrane and genome encapsidation is an important step in the replication of enveloped viruses. The biogenesis of the
poxviral primary membrane and the core as well as the mechanisms of their maturation are poorly understood. Using RNA interference approach,
we demonstrate that a cellular trans-Golgi network membrane protein, golgin-97, is essential for virus replication. Analysis of the virion
morphology in the cells depleted of golgin-97 shows that the protein is required for the virus morphogenesis and, in particular, for the formation of
the first infectious virus form, mature virus, but not its precursor, immature virus. This suggests that golgin-97 may be involved in the maturation
of the virus core and, potentially, the virus membrane.
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Many animal viruses possess a lipid envelope derived from
cellular membranes that protects the nucleocapsid and aids virus
entry to the host cell. Poxviruses, the largest and most complex
of the viruses sequentially acquire two envelopes during the
morphogenesis and produce four structurally and functionally
distinct infectious virion particles. The primary membrane is
initially acquired during assembly of the uninfectious immature
virus (IV) (Condit et al., 2006; Smith and Law, 2004).
Maturation of this membrane accompanying by the virus core
assembly and/or proteolytic processing and condensation
transforms IV into the first infectious virus form, the
intracellular mature virus or mature virus (MV) according to
recently introduced new terminology (Byrd and Hruby, 2006;
Condit et al., 2006; Moss, 2006; Smith and Law, 2004).
Wrapping of the IMV by the secondary membrane leads to
formation of the other three virion types, intracellular
enveloped/wrapped virus (WV), cell-associated enveloped/
extracellular virus (CEV), and extracellular enveloped/unat-⁎ Corresponding author. Fax: +1 541 737 2440.
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doi:10.1016/j.virol.2007.01.003tached extracellular virus (EV) (Condit et al., 2006; Moss, 2006;
Smith and Law, 2004). It is generally accepted that the
secondary membrane derives from budding of MV particles
through the trans-Golgi network (TGN) and/or early endo-
somes (Tooze et al., 1993; van Eijl et al., 2002), whereas the
source of the MV membrane and the mechanisms of its
biogenesis are actively debated. Now, there are three hypotheses
for the mechanisms of the primary membrane generation. First,
since the composition of the membrane seems to be different
from that of the cellular membranes, researchers hypothesized
that the primary membrane is synthesized de novo during viral
infection (Dales and Mosbach, 1968). Second, based on the
experiments showing accumulation of MVenvelope proteins at
the endoplasmic reticulum (ER)–Golgi intermediate compart-
ment (ERGIC) (Krijnse-Locker et al., 1996; Salmons et al.,
1997) as well as labeling of the membranes surrounding MV
precursor, IV particles with markers from the same compart-
ment (Sodeik et al., 1993), it was suggested that the membrane
originates from the ERGIC. In order to test this hypothesis, a
dominant-negative mutant of Sar1, a small GTPase involved in
coatomer protein (COP) II-mediated transport from the ER to
the ERGIC and other post-ER compartments was transiently
expressed in vaccinia virus (VV)-infected cells (Husain and
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was able to block protein transport from the ER, it did not
interfere with IV and MV assembly indicating that the primary
membrane may originate in the ER compartment itself. Further
investigation of this problem has demonstrated that a pathway
between the ER and assembling primary membranes exists at
least for one of the viral membrane proteins, A9L (Husain et al.,
2006). All attempts to detect either ER or ERGIC marker
proteins in purified MV particles and confirm one of the models
have been unsuccessful (Krauss et al., 2002). Recently, using
VV and cowpox virus as model organisms, we have demon-
strated that a host protein residing at the TGN membrane,
golgin-97 (97 kDa), becomes associated with the insoluble
virion core proteins and incorporates into MV particles
(Alzhanova and Hruby, 2006). These findings were surprising
and unexpected because previous experiments with brefeldin A
have shown that intact Golgi complex and COPI-mediated
transport pathway from the Golgi to the ER is not required for
MVassembly (Ulaeto et al., 1995). Consistent with its ability to
assume a coiled-coil stick-like conformation, golgin-97 seems
to penetrate MVenvelope and protrude from the virion surface.
In the infected cell, golgin-97 was shown to re-locate to the
virus replication and assembly factories between 6 and 24 hours
post infection (hpi) (Alzhanova and Hruby, 2006). These data
led to a new hypothesis, based on which we proposed that as a
membrane-associated protein, golgin-97 may play a role in MV
membrane biogenesis by facilitating delivery of the TGN
membranes and, possibly, associated protein factors required for
its maturation to the sites of virion assembly.
In the reported work, we use a RNA interference (RNAi)
approach in order to test our hypothesis and investigate the role
of golgin-97 protein in VV replication. Our results demonstrateFig. 1. (A) dsRNA-1 and dsRNA-2 target sites within golgin-97 mRNA. (B) RNA
dsRNA-1, dsRNA-2, or the negative RNAi control. The relative levels of golgin-97
evaluated by immunoblot analysis. (C) Immunoblot analysis of golgin-97 expression
with 30 pmol of dsRNA-1 and the negative RNAi control (“NC”) or 20 pmol of ds
blotted, and incubated either with anti-golgin-97 antibodies or with anti-actin antibo
proteins.that depletion of the protein significantly affected virus
replication. Electron microscopic analysis revealed that the
protein is essential for virus morphogenesis at the IV maturation
stage, but not for acquisition of the primary membrane
surrounding IV particles.
Results and discussion
To study the potential role of golgin-97 in VV morpho-
genesis and replication we employed a RNAi approach to
suppress golgin-97 expression inside the infected cell. To
induce RNAi we tested two double-stranded (ds) oligoribo-
nucleotides, dsRNA-1 and dsRNA-2 with non-overlapping
target sites within golgin-97 mRNA (Fig. 1A). In order to
analyze RNAi dose response and optimize the conditions,
each dsRNA was titrated. As a negative control for potential
dsRNA-induced side effects, we used double-stranded
oligoribonucleotides with minimized sequence homology to
vertebrate transcripts. Fig. 1B demonstrates that golgin-97
expression was significantly repressed by both dsRNAs at
relatively low concentrations. Decreasing protein levels
corresponded well with increasing amounts of each dsRNA
and reached a minimum at 30 pmol (10%) and 20 pmol
(18%) for dsRNA-1 and dsRNA-2, respectively (Figs. 1B, C).
Anti-actin antibodies used as a control for non-specific RNAi
effect on expression of unrelated proteins showed that
inhibition of golgin-97 expression did not interfere with
actin accumulation (Fig. 1C). Confirming the immunoblotting
results, immunofluorescence experiments (Fig. 2; Supplemen-
tary Figs. S1 and S2) showed striking difference in levels of
golgin-97 accumulation and redistribution between the negative
RNAi control and each dsRNA.i dose–response curve. HeLa cells were transfected with indicated amounts of
expression, “dsRNA-1” or “dsRNA-2” versus “Negative RNAi control” were
in the presence of golgin-97 targeting dsRNAs. Normalized samples transfected
RNA-2 and the negative RNAi control (“NC”) were separated on SDS–PAGE,
dies used as a control for non-specific RNAi effect on expression of unrelated
Fig. 2. VV replication in golgin-97-depleted cells by confocal laser scanning microscopy. HeLa cells transfected with dsRNA-1, dsRNA-2 or negative RNAi control
(“NC”) were infected with VVWR at a MOI of 5.0 pfu/cell and fixed at 24 hpi. The cells were stained with primary antibodies to golgin-97 and VV protein I3L used as
a marker for infected cells and secondary antibodies conjugated to Alexa Fluor 488 (green channel) and TRITC (red channel), respectively. Host and viral DNAwere
stained with DAPI (blue channel). All panels show merged 3-D images. The size of each bar is 20 μm. White arrows show viral factories organized in the absence of
golgin-97.
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HeLa cells were transfected with either dsRNA-1 or dsRNA-2
and infected with VV Western Reserve (WR) strain at a
multiplicity of infection (MOI) of 5.0 plaque-forming units
(pfu) per cell. Surprisingly, VV replication was significantly
affected by both dsRNAs. Reduction in virus titers estimated as
85% (dsRNA-1) and 73% (dsRNA-2) correlated with the loss of
golgin-97 expression (Table 1) implying that the protein is
essential for virus replication.
To decipher the inhibitory effects of golgin-97 depletion on
VV replication the infected cells were analyzed by immuno-
fluorescence. Repression of the protein expression did not
appear to interfere with either virus entry into the cell or its
ability to establish replication factories (Fig. 2; Supplementary
Figs. S1 and S2). Golgin-97 accumulated normally inside the
factories in the presence of the negative RNAi control and as
expected was absent in dsRNA-1 and dsRNA-2 treated samples
(Fig. 2; Supplementary Figs. S1 and S2). These results
suggested that golgin-97 may act at the late steps of virusTable 1
Relative reduction in golgin-97 expression and virus replication efficiency in the pr
Targets site (nt) Relative reduction in
protein expression (%)
Efficiency of virus replica
Golgin-97 dsRNA
dsRNA-1
1305–1329 90 4.79×108±1.89×108
dsRNA-2
1349–1373 82 9.50×108±4.50×108
HeLa cells transfected with dsRNA-1, dsRNA-2 or negative RNAi control were inf
titrated by plaque assay.infection such as virion assembly/maturation or virion translo-
cation within the infected cell. This interpretation would be
consistent with the fact that golgin-97 is a membrane protein
(Barr, 1999; Gleeson et al., 2004; Munro and Nichols, 1999)
and that it was shown to play a role in exocytosis, the pathway
used by many enveloped viruses to exit the cell (Lu et al., 2004).
To test this hypothesis we examined virion morphology at
24 hpi by electron microscopy. In the presence of the negative
RNAi control, virion assembly and maturation were not affected
(Figs. 3A, D). In contrast, depletion of golgin-97 resulted in the
loss of MV particles and dramatic increase in the number of IVs
(Figs. 3B, C, E–I). To rule out the possibility of a delay in virus
morphogenesis, we compared the data of virus replication
assays at 24 hpi and 48 hpi. There was no significant difference
or noticeable increase in relative efficiency of virus replication
for 48 hpi samples (data not shown). Interestingly, some of the
examined cells also contained variable amounts of IV with
nucleoid (IVn), an intermediate form in IV maturation stage that
normally can be seen at early hours in the infection cycle (Figs.esence of dsRNA-1 and dsRNA-2
tion (pfu/ml) Relative reduction in
virus replication (%)
p-value
Negative RNAi control
3.30×109±1.44×109 85 0.5×10−7
3.51×109±1.94×109 73 0.3×10−7
ected with VV WR at an MOI of 5.0 pfu/cell. At 48 hpi the progeny virus was
Fig. 3. VV morphogenesis in golgin-97-depleted cells by electron microscopy of ultrathin sections. HeLa cells transfected with negative RNAi control (A and D),
dsRNA-1 (B, E, G–I) or dsRNA-2 (C and F) were infected with VVWR at anMOI of 5.0 pfu/cell. At 24 hpi the cells were fixed and processed for electron microscopy
analysis. MT and Nu refer to mitochondria and nuclei, respectively. Immature virions, immature virions with nucleoid, abnormal virions (IVn-MV stage), and mature
virions are labeled as IV, IVn, IVn′, and MV, respectively. The size of each bar is 1 μm.
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an intermediate between IVn and MV (Figs. 3E, F, I; IVn′). This
observation could be explained by the incomplete suppression
of golgin-97 expression and indicate that the protein may act at
IVn formation, although we cannot exclude that it may be
important for the next stage, IVn–MV as well.
Based on the data described here and the results of our previous
experiments (Alzhanova and Hruby, 2006) we propose a model of
the MV biogenesis (Fig. 4) and suggest a host cell protein, golgin-
97, as a key player in this process. Although the mechanisms and
the functions of the protein are yet to be determined, one of the
possible scenarios may be that when attached to the TGN
membrane at the C-terminus, golgin-97 delivers its fragments
along with associated protein factors required for maturation of the
virus core and, potentially, virus membrane to the virion assembly
sites upon its relocation inside the factories. Supporting thishypothesis, a processed form of transiently expressed C-terminal
but not N-terminal FLAG:golgin-97 fusion protein was detected
inside the virions (Alzhanova and Hruby, 2006). In this process,
golgin-97 is likely to associate with the proteins comprising
insoluble core fraction and incorporate into IVn particles while
they are being assembled. Alternatively, golgin-97 may be
attached to the nascent viral membranes via a viral or cellular
protein co-factors in a manner similar to its association with the
TGN membrane (Lu and Hong, 2003; Panic et al., 2003; Setty
et al., 2003; Wu et al., 2004) and become passively incorporated
during IV/IVn assembly. In this case, the protein may simply
play a role of a structural protein: its packaging may contribute
to the formation and/or stabilization of the condensed core
structure. In addition to this, the surface exposed part of the
protein may be involved in the transportation of the assembled
MV particles to the TGN compartment where they acquire the
Fig. 4. Working model. During poxvirus infection, a host cell protein, golgin-97
translocates into the viral factories. Being anchored to the TGN membrane, the
protein may transport the membrane fragments and associated protein factors
important for virus maturation to the sites of virion assembly. Via its association
with viral core proteins, golgin-97 incorporates into the virion and aids IVn/MV
assembly. Alternatively, the protein may be attached to the nascent viral
membrane via a viral or cellular protein co-factors and incorporate into virions
during IV/IVn assembly, in this case, playing a role of a structural protein only.
In addition to this, being exposed at the virion surface golgin-97 may traffic-
assembled IMV particles to the TGN compartment where they become wrapped
by the secondary membrane.
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support the existing hypothesis about the TGN as the origin of
the secondary membrane. Further investigation of golgin-97
functions in virus morphogenesis and the experimental verifica-
tion of the proposed model will undoubtedly provide new
insights on the mechanisms of host–pathogen interactions,
revealing yet another example of how viruses exploit cellular
proteins and pre-existing pathways to serve their needs. As to
continuous efforts in developing smallpox vaccines and
discovery of anti-poxvirus drugs, these data have identified
new potential targets, virus proteins that facilitate golgin-97
delivery inside the virus factories and its incorporation into the
virions, as well as golgin-97 itself.Materials and methods
Cells and viruses
HeLa cells were grown in minimal essential medium (MEM)
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS). Vaccinia virus Western Reserve (WR) strain was
propagated and purified as described previously (Hruby et al.,
1979).
Double-stranded oligoribonucleotides
Stealth siRNA 25-bp-long duplex oligoribonucleotides tar-
geting golgin-97 mRNA sequence, GOLGA1-HSS104275 (5′-AAGAGCUGUUGUCUGGUAUCCUCCA-3′) and GOLGA1-
HSS104276 (5′-UCUCCAGGGUGUUAAUGGCCUUAGC-
3′) referenced as dsRNA-1 and dsRNA-2, respectively, were
purchased from Invitrogen. As RNAi negative control, we have
used Stealth RNAi Negative control Duplex oligoribonucleotide
(Invitrogen) with medium GC content (48%).
Antibodies
Anti-human golgin-97 mouse monoclonal antibodies and
rabbit anti-actin (AA 20–33) antibodies were purchased from
Invitrogen and Sigma (Sigma-Aldrich, Inc., Saint Louis, MO),
respectively. Rabbit polyclonal anti-I3L antibodies (5) were
kindly provided by J. Krijnse-Locker (EMBL, Heidelberg,
Germany).
RNAi induction and virus replication assay
HeLa cells were plated on glass coverslips in 6-well plates
at 20% confluency. The next day, the cells were transfected
with double-stranded oligoribonucleotides using Lipofecta-
mine 2000 (Invitrogen) according to manufacturer's protocol.
For RNAi dose–response experiment, double-stranded oligor-
ibonucleotide concentrations were 5 pmol, 10 pmol, 20 pmol,
30 pmol, and 40 pmol. For all other experiments, the cells
were transfected with 30 pmol of a double-stranded
oligoribonucleotide. After 72 h incubation, the cells were
either harvested and processed for immunoblot analysis or
infected with VV WR strain at a multiplicity of infection
(MOI) of 5.0 plaque-forming units (pfu) per cell and
incubated for 48 h. Titration of the virus was carried out
according to previously described protocol (Hruby et al.,
1979). The infected cells were harvested and centrifuged at
700×g at 4 °C. The pellet was resuspended in phosphate-
buffered saline (PBS) and subjected to three cycles of freeze/
thaw in liquid nitrogen and 37 °C water bath. The samples
were titrated on BSC-40 cells and stained with 0.1% crystal
violet (Sigma-Aldrich, Inc.) in 30% ethanol.
Immunofluorescence staining
HeLa cells were plated on glass coverslips in 24-well plates
at 20% confluency. The next day, the cells were transfected with
12 pmol of the double-stranded oligoribonucleotide using
Lipofectamine 2000 (Invitrogen) according to manufacturer's
protocol. The cells were infected with vaccinia virus strain WR
at a MOI of 5.0 pfu/cell after 72 h of incubation. At the 24 hpi,
the cells were fixed with 100% methanol for 10 min. The
coverslips were washed three times with PBS, blocked in P-
bovine serum albumin (BSA) (PBS–2% BSA, pH 7.4) for
30 min and incubated with primary anti-I3L (1:2000) and anti-
golgin-97 (1 μg/ml) diluted in P-BSA for 1 h. The cells were
washed three times with PBS and once with P-BSA and then
incubated with anti-rabbit (Southern Biotechnology Associates,
Inc, Birmingham, AL) and anti-mouse (Invitrogen) antibodies
conjugated to TRITC and Alexa Fluor 488, respectively. The
coverslips were mounted in ProLong Gold antifade reagent with
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confocal laser scanning microscope. The channels were
collected in multi track mode. Alternatively, the cells were
examined at 1000× magnification using a Leika fluorescence
microscope. The images were collected with SPOT digital
camera system (Diagnostics Instruments, Inc., Sterling Heights,
MI).
Electron microscopy
HeLa cells were plated at 6-well plates at 20% confluency.
The next day, the cells were transfected with either negative
RNAi control or dsRNA-1 or dsRNA-2 as described above. The
cells were infected with VV WR at a MOI of 5.0 pfu/cell after
72 h of incubation. At 24 hpi, the cell were scraped from the
plates, resuspended in culture medium and pelleted by
centrifugation at 700×g at 4 °C. The cells were fixed in 1%
paraformaldehyde, 0.5% glutaraldehyde, 200 mM cacodylate
buffer (pH 7.4) for 4 h. Embedding in LR White resin and
sectioning was performed by personnel of the Oregon State
University EM laboratory. The thin sections were placed on
uncoated gold 300 mesh grids and stained with lead citrate and
uranyl acetate. The samples were examined on a Philips EM
300 electron microscope.
Immunoblot analysis
Harvested cells were pelleted by centrifugation at 700×g at
4 °C and resuspended in 10 mM Tris (pH 8.0). The cells were
lysed by freeze–thawing and cleared by centrifugation at
1500×g, 4 °C. The samples were normalized based on
measured OD A280. Proteins were separated by sodium
dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis
(PAGE) and transferred to PVDF-membrane (Immobilon-
PSQ, Millipore, Billerica, MA). The membrane was blocked
in 3% gelatin in TTBS (0.05% Tween 20 – 150 mM NaCl –
50 mM Tris–HCl, pH 7.4) and incubated with primary anti-
golgin-97 (1 μg/ml) or anti-actin antibodies (1:1000) in 1%
gelatin–TTBS overnight. The membrane was washed three
times in TTBS and incubated with secondary anti-mouse
(Invitrogen) or anti-rabbit (Promega, San Luis Obispo, CA)
antibodies conjugated to horseradish peroxidase (HRP). The
proteins were detected with a chemiluminescence kit (West-
Pico; Pierce Biotechnology, Inc., Rockford, IL).
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